| Issue |
Section |
Title |
File |
| Vol 15, No 2 (2013) |
Articles |
Role of vemurafenib in the treatment of disseminated skin melanoma |
|
| Vol 16, No 1 (2014) |
Articles |
Overcoming immunological tolerance is a way of treating malignant tumors: new perspectives |
|
| Vol 19, No 4 (2017) |
Articles |
Head and neck cutaneous melanoma: an influence of surgical resection margin on long-term results |
(Rus)
|
| Vol 25, No 1 (2023) |
CLINICAL ONCOLOGY |
Immunological detection of bone marrow lesions in skin melanoma and its clinical significance: Observational study |
(Rus)
|
| Vol 24, No 4 (2022) |
CLINICAL ONCOLOGY |
Real-world efficacy of the first line therapy with prolgolimab in patients with metastatic melanoma: interim results of the FORA (FOrteca Real practice Assessment) observational study |
(Rus)
|
| Vol 25, No 1 (2023) |
CLINICAL ONCOLOGY |
Combination of encorafenib and binimetinib in the treatment of patients with BRAF-mutated advanced melanoma. Case report |
(Rus)
|
| Vol 25, No 3 (2023) |
CLINICAL ONCOLOGY |
Efficacy and safety of nurulimab+prolgolimab with continued prolgolimab therapy compared to prolgolimab alone as first-line therapy in patients with unresectable or metastatic melanoma: final results of the phase II OBERTON clinical study |
(Rus)
|
| Vol 26, No 1 (2024) |
Articles |
Final data on the efficacy of the FORA study (FOrteca Real practice Assessment): a multicenter prospective observational study on the real-world efficacy of prolgolimab in patients with metastatic melanoma in Russia |
(Rus)
|
| Vol 26, No 1 (2024) |
Articles |
Detection of mutations in the BRAF in patients with melanoma in routine clinical practice: Survey results |
(Rus)
|
| Vol 27, No 1 (2025) |
Articles |
Basal cell skin carcinoma: Epidemiology of locally advanced and metastatic forms based on the data of the N.N. Blokhin National Medical Research Center of Oncology: A retrospective study |
(Rus)
|
